The Experts below are selected from a list of 28848 Experts worldwide ranked by ideXlab platform
Victoria Delgado - One of the best experts on this subject based on the ideXlab platform.
-
Multimodality Imaging in the diagnosis, risk stratification, and management of patients with dilated cardiomyopathies an expert consensus document from the European Association of Cardiovascular Imaging
European Heart Journal - Cardiovascular Imaging, 2019Co-Authors: Erwan Donal, Victoria Delgado, Chiara Bucciarelli-ducci, Elena Galli, Kristina H Haugaa, Philippe Charron, Jens-uwe Voigt, Nuno Cardim, P G Masci, Maurizio GalderisiAbstract:Dilated cardiomyopathy (DCM) is defined by the presence of left ventricular or biventricular dilatation and systolic dysfunction in the absence of abnormal loading conditions or coronary artery disease sufficient to explain these changes. This is a heterogeneous disease frequently having a genetic background. Imaging is important for the diagnosis, the prognostic assessment and for guiding therapy. A Multimodality Imaging approach provides a comprehensive evaluation of all the issues related to this disease. The present document aims to provide recommendations for the use of Multimodality Imaging according to the clinical question. Selection of one or another Imaging technique should be based on the clinical condition and context. Techniques are presented with the aim to underscore what is 'clinically relevant' and what are the tools that 'can be used'. There remain some gaps in evidence on the impact of Multimodality Imaging on the management and the treatment of DCM patients where ongoing research is important.
-
transcatheter interventions for mitral regurgitation Multimodality Imaging for patient selection and procedural guidance
Jacc-cardiovascular Imaging, 2019Co-Authors: Jeroen J. Bax, Patrizio Lancellotti, James K. Min, Rebecca T Hahn, Jonathon Leipsic, Nina Ajmone Marsan, Philippe Debonnaire, Laurens F Tops, Niccolo Piazza, Victoria DelgadoAbstract:Transcatheter therapies to treat mitral regurgitation are rapidly developing. Currently, there are several devices commercially available to treat mitral regurgitation. The underlying cause of mitral regurgitation and specific anatomical aspects of the mitral valve and surrounding structures are considered when patients with symptomatic severe mitral regurgitation for transcatheter mitral valve therapies are selected. Multimodality Imaging plays an important central role in the selection of patients, providing information about the mechanism of mitral regurgitation, the anatomy of the mitral valve and spatial relationships with the coronary sinus, the circumflex coronary artery and left ventricular outflow tract and to predict the procedural outcomes. During the transcatheter procedure, transesophageal echocardiography and fluoroscopy are key for monitoring the procedural steps to maximize the outcomes and minimize the complications. This paper provides a comprehensive review of the most important aspects to visualize in order to appropriately select patients for transcatheter mitral valve repair and replacement and to guide the procedure for the different transcatheter devices.
-
Multimodality Imaging in cardiology : a statement on behalf of the Task Force on Multimodality Imaging of the European Association of Cardiovascular Imaging
European heart journal, 2018Co-Authors: Kevin F. Fox, Stephan Achenbach, Jeroen J. Bax, Bernard Cosyns, Victoria Delgado, Marc R. Dweck, Thor Edvardsen, Frank A. Flachskampf, Gilbert Habib, Patrizio LancellottiAbstract:Multimodality Imaging in cardiology : a statement on behalf of the Task Force on Multimodality Imaging of the European Association of Cardiovascular Imaging
-
Multimodality Imaging in transcatheter aortic valve implantation key steps to assess procedural feasibility
Eurointervention, 2010Co-Authors: Victoria Delgado, See Hooi Ewe, Frank Van Der Kley, Nina Ajmone Marsan, Joanne D Schuijf, Martin J Schalij, Jeroen J. BaxAbstract:Transcatheter aortic valve implantation (TAVI) has been an important breakthrough in the treatment of patients with symptomatic, severe aortic stenosis and contraindications for surgical aortic valve replacement. Accurate aortic root measurements and evaluation of spatial relationships with the coronary ostia are crucial in pre-operative TAVI assessment. In addition, characterisation of the peripheral artery anatomy and aorta is an important key step in the procedural feasibility evaluation. The present review article provides a practical approach, based on Multimodality Imaging, to select candidates for TAVI and to evaluate the procedural feasibility.
Bernard Cosyns - One of the best experts on this subject based on the ideXlab platform.
-
Multimodality Imaging in cardiology : a statement on behalf of the Task Force on Multimodality Imaging of the European Association of Cardiovascular Imaging
European heart journal, 2018Co-Authors: Kevin F. Fox, Stephan Achenbach, Jeroen J. Bax, Bernard Cosyns, Victoria Delgado, Marc R. Dweck, Thor Edvardsen, Frank A. Flachskampf, Gilbert Habib, Patrizio LancellottiAbstract:Multimodality Imaging in cardiology : a statement on behalf of the Task Force on Multimodality Imaging of the European Association of Cardiovascular Imaging
-
Multimodality Imaging strategies for the assessment of aortic stenosis viewpoint of the heart valve clinic international database havec group
Circulation-cardiovascular Imaging, 2016Co-Authors: Raluca Dulgheru, Erwan Donal, Philippe Pibarot, Partho P Sengupta, Luc Pierard, Raphael Rosenhek, Julien Magne, Anne Bernard, Khalil Fattouch, Bernard CosynsAbstract:Aortic stenosis is the most frequent valvular heart disease. In aortic stenosis, therapeutic decision essentially depends on symptomatic status, stenosis severity, and status of left ventricular systolic function. Surgical aortic valve replacement or transcatheter aortic valve implantation is the sole effective therapy in symptomatic patients with severe aortic stenosis, whereas the management of asymptomatic patients remains controversial and is mainly based on individual risk stratification. Imaging is fundamental for the initial diagnostic work-up, follow-up, and selection of the optimal timing and type of intervention. The present review provides specific recommendations for utilization of Multimodality Imaging to optimize risk stratification and therapeutic decision-making processes in aortic stenosis.
-
european association of cardiovascular Imaging eacvi position paper Multimodality Imaging in pericardial disease
European Journal of Echocardiography, 2015Co-Authors: Bernard Cosyns, Stephan Achenbach, Massimo Imazio, Sven Plein, Petros Nihoyanopoulos, Otto A Smiseth, Maria Joao Andrade, Mauro Pepi, Arsen Ristic, Bernard P PaelinckAbstract:Although pericardial diseases are common in the daily clinical practice and can result in a significant morbidity and mortality, Imaging of patients with suspected or known pericardial disorders remain challenging. Multimodality Imaging is part of the management of pericardial diseases. Echocardiography, cardiac computed tomography, and cardiovascular magnetic resonance are often used as complementary Imaging modalities. The choice of one or multiple Imaging modalities is driven by the clinical context or conditions of the patient. The scope of the present document is to highlight the respective role of each technique according to the clinical context in the diagnosis and management of pericardial diseases.
Raluca Dulgheru - One of the best experts on this subject based on the ideXlab platform.
-
Multimodality Imaging strategies for the assessment of aortic stenosis viewpoint of the heart valve clinic international database havec group
Circulation-cardiovascular Imaging, 2016Co-Authors: Raluca Dulgheru, Erwan Donal, Philippe Pibarot, Partho P Sengupta, Luc Pierard, Raphael Rosenhek, Julien Magne, Anne Bernard, Khalil Fattouch, Bernard CosynsAbstract:Aortic stenosis is the most frequent valvular heart disease. In aortic stenosis, therapeutic decision essentially depends on symptomatic status, stenosis severity, and status of left ventricular systolic function. Surgical aortic valve replacement or transcatheter aortic valve implantation is the sole effective therapy in symptomatic patients with severe aortic stenosis, whereas the management of asymptomatic patients remains controversial and is mainly based on individual risk stratification. Imaging is fundamental for the initial diagnostic work-up, follow-up, and selection of the optimal timing and type of intervention. The present review provides specific recommendations for utilization of Multimodality Imaging to optimize risk stratification and therapeutic decision-making processes in aortic stenosis.
-
Multimodality Imaging strategies for the assessment of aortic stenosis: Viewpoint of the heart valve clinic international database (HAVEC) group
Circulation: Cardiovascular Imaging, 2016Co-Authors: Raluca Dulgheru, Philippe Pibarot, Partho P Sengupta, Luc Pierard, Raphael Rosenhek, Julien Magne, Anne Bernard, Khalil Fattouch, E. Donal, B. CosynsAbstract:Aortic stenosis is the most frequent valvular heart disease. In aortic stenosis, therapeutic decision essentially depends on symptomatic status, stenosis severity, and status of left ventricular systolic function. Surgical aortic valve replacement or transcatheter aortic valve implantation is the sole effective therapy in symptomatic patients with severe aortic stenosis, whereas the management of asymptomatic patients remains controversial and is mainly based on individual risk stratification. Imaging is fundamental for the initial diagnostic work-up, follow-up, and selection of the optimal timing and type of intervention. The present review provides specific recommendations for utilization of Multimodality Imaging to optimize risk stratification and therapeutic decision-making processes in aortic stenosis. © 2016 American Heart Association, Inc.
Jeroen J. Bax - One of the best experts on this subject based on the ideXlab platform.
-
transcatheter interventions for mitral regurgitation Multimodality Imaging for patient selection and procedural guidance
Jacc-cardiovascular Imaging, 2019Co-Authors: Jeroen J. Bax, Patrizio Lancellotti, James K. Min, Rebecca T Hahn, Jonathon Leipsic, Nina Ajmone Marsan, Philippe Debonnaire, Laurens F Tops, Niccolo Piazza, Victoria DelgadoAbstract:Transcatheter therapies to treat mitral regurgitation are rapidly developing. Currently, there are several devices commercially available to treat mitral regurgitation. The underlying cause of mitral regurgitation and specific anatomical aspects of the mitral valve and surrounding structures are considered when patients with symptomatic severe mitral regurgitation for transcatheter mitral valve therapies are selected. Multimodality Imaging plays an important central role in the selection of patients, providing information about the mechanism of mitral regurgitation, the anatomy of the mitral valve and spatial relationships with the coronary sinus, the circumflex coronary artery and left ventricular outflow tract and to predict the procedural outcomes. During the transcatheter procedure, transesophageal echocardiography and fluoroscopy are key for monitoring the procedural steps to maximize the outcomes and minimize the complications. This paper provides a comprehensive review of the most important aspects to visualize in order to appropriately select patients for transcatheter mitral valve repair and replacement and to guide the procedure for the different transcatheter devices.
-
Multimodality Imaging in cardiology : a statement on behalf of the Task Force on Multimodality Imaging of the European Association of Cardiovascular Imaging
European heart journal, 2018Co-Authors: Kevin F. Fox, Stephan Achenbach, Jeroen J. Bax, Bernard Cosyns, Victoria Delgado, Marc R. Dweck, Thor Edvardsen, Frank A. Flachskampf, Gilbert Habib, Patrizio LancellottiAbstract:Multimodality Imaging in cardiology : a statement on behalf of the Task Force on Multimodality Imaging of the European Association of Cardiovascular Imaging
-
Multimodality Imaging in transcatheter aortic valve implantation key steps to assess procedural feasibility
Eurointervention, 2010Co-Authors: Victoria Delgado, See Hooi Ewe, Frank Van Der Kley, Nina Ajmone Marsan, Joanne D Schuijf, Martin J Schalij, Jeroen J. BaxAbstract:Transcatheter aortic valve implantation (TAVI) has been an important breakthrough in the treatment of patients with symptomatic, severe aortic stenosis and contraindications for surgical aortic valve replacement. Accurate aortic root measurements and evaluation of spatial relationships with the coronary ostia are crucial in pre-operative TAVI assessment. In addition, characterisation of the peripheral artery anatomy and aorta is an important key step in the procedural feasibility evaluation. The present review article provides a practical approach, based on Multimodality Imaging, to select candidates for TAVI and to evaluate the procedural feasibility.
B. Cosyns - One of the best experts on this subject based on the ideXlab platform.
-
Multimodality Imaging strategies for the assessment of aortic stenosis: Viewpoint of the heart valve clinic international database (HAVEC) group
Circulation: Cardiovascular Imaging, 2016Co-Authors: Raluca Dulgheru, Philippe Pibarot, Partho P Sengupta, Luc Pierard, Raphael Rosenhek, Julien Magne, Anne Bernard, Khalil Fattouch, E. Donal, B. CosynsAbstract:Aortic stenosis is the most frequent valvular heart disease. In aortic stenosis, therapeutic decision essentially depends on symptomatic status, stenosis severity, and status of left ventricular systolic function. Surgical aortic valve replacement or transcatheter aortic valve implantation is the sole effective therapy in symptomatic patients with severe aortic stenosis, whereas the management of asymptomatic patients remains controversial and is mainly based on individual risk stratification. Imaging is fundamental for the initial diagnostic work-up, follow-up, and selection of the optimal timing and type of intervention. The present review provides specific recommendations for utilization of Multimodality Imaging to optimize risk stratification and therapeutic decision-making processes in aortic stenosis. © 2016 American Heart Association, Inc.